The federal government is paying more attention to drug shortage issues, fueled in part by activism from the American Society of Anesthesiologists, according to an ASA release.
On Sept. 23, the House Energy and Commerce Health Subcommittee held a hearing on "Examining the Increase in Drug Shortages." Among those testifying before the Congressional panel were members of the Drug Shortage Summit Legislative and Regulatory Work Group, a group of stakeholders initially brought together in Nov. 2010 and currently functioning as an informal coalition to advance drug shortage solutions.
On Sept. 26, the FDA held a public workshop on drug shortages. ASA physicians and staff worked closely with the FDA on the program for the meeting, which included a report on the impact of drug shortages on anesthesiologists and patients.
Related Articles on Anesthesia:
74% of Michigan Residents Understand What Anesthesiologists Do
Researchers Map Molecular Pathways Used by Common Pain Drug
Dr. Michael Humphrey Discusses Draw, Downsides of Anesthesiology
On Sept. 23, the House Energy and Commerce Health Subcommittee held a hearing on "Examining the Increase in Drug Shortages." Among those testifying before the Congressional panel were members of the Drug Shortage Summit Legislative and Regulatory Work Group, a group of stakeholders initially brought together in Nov. 2010 and currently functioning as an informal coalition to advance drug shortage solutions.
On Sept. 26, the FDA held a public workshop on drug shortages. ASA physicians and staff worked closely with the FDA on the program for the meeting, which included a report on the impact of drug shortages on anesthesiologists and patients.
Related Articles on Anesthesia:
74% of Michigan Residents Understand What Anesthesiologists Do
Researchers Map Molecular Pathways Used by Common Pain Drug
Dr. Michael Humphrey Discusses Draw, Downsides of Anesthesiology